Conservative endovascular management for intractable delayed hemorrhage after laparoscopic-assisted vaginal hysterectomy: Two case reports. [PDF]
Takeda A +3 more
europepmc +1 more source
ABSTRACT Background Postoperative complications substantially increase morbidity, mortality and healthcare costs. Understanding prognostic factors is essential for risk stratification, targeted prevention strategies, and development of prediction models.
Anders Peder Højer Karlsen +15 more
wiley +1 more source
Case Report: Fully transvaginal extraperitoneal pelvic lymphadenectomy via retropubic access combined with radical vaginal hysterectomy or trachelectomy for early-stage cervical cancer. [PDF]
Huang X, Zhou C, Ou Y.
europepmc +1 more source
Endometriosis (including adenomyosis) is an inflammatory disease with lesions of endometrial tissue outside the uterus or in the uterine wall. In this study on Swedish women, endometriosis or adenomyosis was associated with persistently increased risks of breast and epithelial ovarian cancers, especially clear cell, endometrioid, and low‐grade serous ...
Louise Moberg +6 more
wiley +1 more source
Comparison of vaginal natural orifice transluminal endoscopic surgery and vaginal hysterectomy for benign indications: a prospective randomized controlled study. [PDF]
Yıldız G +7 more
europepmc +1 more source
Bilateral Sacrospinous Hysteropexy Versus Bilateral Sacrospinous Ligament Fixation with Vaginal Hysterectomy for Apical Uterovaginal Prolapse. [PDF]
Wang K, Shi L, Huang Z, Xu Y.
europepmc +1 more source
In this Swedish register‐based cohort study, systemic menopausal hormone therapy dispensing decreased over 15 years, while local therapy increased. Age, cohort effects, and sociodemographic characteristics were associated with differences in dispensing patterns.
Rebecca Götze Eriksson +9 more
wiley +1 more source
Ectopic Prostatic Tissue in the Uterine Cervix Following Vaginal Hysterectomy. [PDF]
Alao AI, Gandhi N, Purwar B.
europepmc +1 more source
Menopausal hormone therapy after ovarian cancer: A 10‐year survival analysis in premenopausal women
Among premenopausal women surgically treated for ovarian cancer, no difference in 10‐year overall survival was observed between postoperative MHT users and non‐users. Young ovarian cancer survivors should be recommended MHT after surgically induced menopause.
Åsa Ehlin von Kartaschew +4 more
wiley +1 more source
Vaginal Hysterectomy of the Didelphic Uterus. [PDF]
White M, Herrell H.
europepmc +1 more source

